1. Background
2. Objectives
3. Methods
| Questions | Correct Answer, No. (%) |
|---|---|
| Age to start and stop screening in normal population | 79 (52.7) |
| Best screening method for moderate risk patients | 76 (50.7) |
| Screening intervals for each method | 103 (68.7) |
| Screening onset age, intervals and methods for patients with a family history of CRC in first degree relatives < 60 years old | 108 (72.0) |
| Screening onset age, intervals and methods for patients with a family history of CRC in first degree relatives > 60 years old | 40 (26.7) |
| Screening onset age, intervals and methods for patients with a family history of CRA in first degree relatives < 60 years old | 63 (42.0) |
| Screening onset age, intervals and methods for patients with a family history of CRA in first degree relatives > 60 years old | 44 (29.3) |
| Screening onset age, intervals and methods for patients with a family history of CRC/CRA in second/third degree relatives | 92 (61.3) |
| Screening intervals for patients with personal history of hyperplastic, left-sided, sessile, and < 1 centimeter in diameter CRA | 21 (14.0) |
| Screening intervals for patients with personal history of hyperplastic, right-sided, sessile, and < 1 centimeter in diameter CRA | 34 (22.7) |
| Screening for patients with personal history of pedunculated or adenomatous CRA | 96 (64.0) |
| Screening onset age, intervals and methods for relatives of FAP patients | 64 (42.7) |
| Diagnostic criteria for HNPCC | 19 (12.7) |
| Screening onset age, intervals and methods for relatives of HNPCC patients | 50 (33.3) |
| Screening intervals for recently treated CRC patients who had not undergone colonoscopy before surgery | 82 (54.7) |
| Screening intervals for recently treated CRC patients who had undergone colonoscopy before surgery | 46 (30.7) |
| Screening intervals for patients who underwent successful treatment > 3 years ago | 85 (56.7) |
| Screening and surveillance in IBD patients | 66 (44.0) |
Abbreviations: CRC, colorectal cancer; CRA, colorectal adenoma; FAP, familial adenomatous polyposis; HNPCC, hereditary nonpolyposis colorectal cancer; IBD, inflammatory bowel disease.
Knowledge of family physicians towards colorectal cancer (CRC) risk factors and signs and symptoms. Frequency of correct answers are presented. A, notice that aspirin and irritable bowel syndrome (IBS) were considered as negative risk factors; also, B, icterus and nausea/vomiting were asked to make the participants think of other diagnoses rather than CRC.
4. Results
| Variables | Values |
|---|---|
| Age (y) | |
| Range: 25 - 55 | 35.4 ± 8.15 |
| Gap after graduation (y) | |
| Range: 1 - 26 | 9.43 ± 7.87 |
| Work experience (y) | |
| Range: 1 - 26 | 8.67 ± 7.45 |
| Gender | |
| Male | 70 (46.7) |
| Female | 80 (53.3) |
| Place of employment | |
| Capital of province | 36 (24.0) |
| Country | 114 (76.0) |
a Values are expressed as mean ± SD or No. (%).
| Knowledge | No. (%) | Mean ± SD | Range |
|---|---|---|---|
| Screening program | 18 (43.16) | 7.77 ± 3.43 | 2 - 16 |
| Risk factors | 13 (79.15) | 10.29 ± 1.83 | 5 - 13 |
| Signs and symptoms | 8 (88.75) | 7.10 ± 0.81 | 5 - 8 |
| Total | 38 (64.38) | 25.11 ± 4.64 | 16 - 35 |
